Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Precision Medicine for Patients With Identified Actionable Mutations [Phase 2]
A Phase 2 precision medicine trial for patients with identified actionable mutations in solid tumors, lymphoma, and multiple myeloma was ter…
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: Phase I/II Study of Avelumab in Pediatric Cancer Participants [Phase 1]
A Phase I/II pediatric trial of avelumab in refractory or relapsed solid tumors and lymphoma was terminated, with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E) [Phase 2]
Phase 2 MATCH subprotocol evaluating AZD9291 (osimertinib) as a targeted treatment for cancers with EGFR genetic changes; the trial is curre…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Amplifications (MATCH-Subprotocol K1) [Phase 2]
Phase 2 trial evaluating Erdafitinib (JNJ-42756493) for cancers with FGFR amplifications; the study includes advanced and refractory lymphom…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: DOLPHIN-VIVO: Diagnosis Of LymPHoma IN Vivo (Ex Vivo Phase)
Update on the DOLPHIN-VIVO trial assessing in vivo diagnosis of lymphoma during the ex vivo phase.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy [NA]
A completed clinical trial evaluating the feasibility of a digital health coaching program for individuals after CAR T-cell therapy.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients [NA]
This clinical trial update notes the completion of a study evaluating Elly, a mobile audio companion, intended to reduce anxiety in cancer p…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors [Phase 1, Phase 2]
This completed Phase 1/2 study evaluated the safety and preliminary efficacy of combining surufatinib with gemcitabine in pediatric, adolesc…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas [Phase 1, Phase 2]
This clinical trial update reports the completion and posted results of a Phase 1/2 study evaluating TRC102 in combination with Temozolomide…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma [Phase 1]
A Phase 1 study of CPI-0610 in patients with progressive lymphoma has completed. The update notes the trial status as completed.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) [Phase 2]
Phase 2 pediatric trial of Genistein for various cancers was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants [Phase 1]
A Phase 1 trial evaluating the safety and tolerability of SYNB1891 alone or with atezolizumab in adults with metastatic solid tumors or lymp…
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Chaplain-Delivered Compassion Meditation to Improve Quality of Life in Patients Receiving a Stem Cell Transplant [NA]
A completed clinical trial evaluating chaplain-delivered compassion meditation to improve quality of life in patients undergoing stem cell t…
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Radiation Post-CAR T in Refractory Lymphoma [NA]
A clinical trial evaluating radiation after CAR T therapy in refractory lymphoma was terminated. Results were posted on 2024-04-10.
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: A Pilot RCT of the PRISM Intervention for AYAs With Cancer [Phase 2]
pilot randomized Phase 2 trial evaluating the PRISM intervention for adolescents and young adults with cancer, completed.
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) [Phase 1, Phase 2]
Phase 1/2 clinical trial update on NK donor lymphocyte infusion following HLA-haploidentical HSCT; study status completed.
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma [Phase 1, Phase 2]
Clinical trial of mocetinostat in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101 [Phase 1]
Phase 1 trial of intratumorally administered STING agonist E7766 in advanced solid tumors or lymphomas has been terminated with results post…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001) [Phase 1]
Phase 1 study of Ulevostinag (MK-1454) alone or in combination with pembrolizumab (MK-3475) in participants with advanced/metastatic solid t…
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma [Phase 1, Phase 2]
A study investigating CYC140 in subjects with advanced solid tumors and lymphoma (Phase 1/Phase 2) is listed with unknown status.
-
CLINICAL_TRIALS trial_result · 2024-01-25Clinical Trial Update: A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma [Phase 1, Phase 2]
Clinical trial update for Fadraciclib (CYC065) in advanced solid tumors and lymphoma (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801) [Phase 3]
Phase 3 trial comparing TAC/MTX versus TAC/MMF/PTCY for graft-versus-host disease prevention and microbiome/immune reconstitution in patient…
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas [Phase 1]
A pediatric Phase 1 trial evaluating selinexor in children with recurrent or refractory solid tumors and high-grade gliomas has completed. R…
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy [Phase 2]
Phase 2 trial of Xisomab 3G3 for preventing catheter-associated thrombosis in cancer patients undergoing chemotherapy was terminated; result…
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation [Phase 1, Phase 2]
Clinical trial update for a monoclonal antibody therapy in relapsed lymphoma after chemotherapy and autologous stem cell transplantation (Ph…